Q4 2013 Holdings
Filed 2014-02-14 | 23 holdings | $127.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Gentium S P A | SPONSORED ADR | 37250B104 | $29.2M | 505,000 | 23.0% |
| Geron Corp(GERN) | COM | 374163103 | $13.2M | 2,640,000 | 10.4% |
| Pharmacyclics Inc | COM | 716933106 | $13.0M | 120,000 | 10.2% |
| Ariad Pharmaceuticals Inc | COM | 04033A100 | $11.9M | 1,670,000 | 9.3% |
| NPS Pharmaceuticals Inc | COM | 62936P103 | $5.9M | 205,000 | 4.7% |
| Omeros Corp(OMER) | COM | 682143102 | $5.1M | 460,000 | 4.0% |
| Fluidigm Corp del(LAB) | COM | 34385P108 | $5.0M | 132,500 | 4.0% |
| Ligand Pharmaceuticals Inc(LGND) | COM | 53220K504 | $4.9M | 90,000 | 3.8% |
| Cempra Inc | COM | 15130J109 | $4.7M | 365,000 | 3.7% |
| Cardiovascular SYS Inc del(CSIIEUR) | COM | 141619106 | $4.5M | 135,000 | 3.5% |
| Sunshine Heart Inc | COM | 86782U106 | $4.1M | 425,100 | 3.2% |
| Intercept Pharmaceuticals Inc(ICPTUSD) | COM | 45845P108 | $3.6M | 56,900 | 2.9% |
| Inspiremd Inc | COM NEW | 45779A309 | $2.9M | 1,134,400 | 2.3% |
| Novadaq Technologies Inc | COM | 66987G102 | $2.8M | 167,600 | 2.2% |
| Catalyst Pharm Partners Inc(CPRX) | COM | 14888U101 | $2.6M | 1,353,900 | 2.1% |
| Celgene Corp | RIGHT 12/31/2030 | 151020112 | $2.2M | 800,000 | 1.8% |
| Bind Therapeutics Inc | COM | 05548N107 | $2.1M | 155,000 | 1.7% |
| Biolinerx LTD | SPONSORED ADR | 09071M106 | $2.1M | 713,000 | 1.6% |
| Tetraphase Pharmaceuticals Inc | COM | 88165N105 | $2.0M | 153,500 | 1.6% |
| Infinity Pharmaceuticals Inc(INFIQ) | COM | 45665G303 | $1.7M | 130,000 | 1.3% |
| Medivation Inc | COM | 58501N101 | $1.6M | 25,000 | 1.3% |
| Kalobios Pharmaceuticals Inc | COM | 48344T100 | $1.2M | 285,000 | 0.9% |
| Celator Pharmaceuticals Inc | COM | 15089R102 | $961.0K | 310,000 | 0.8% |